|
MTF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.22750000000005E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.602400E-03 |
| Normal-vs-Stage2 |
4.0840000000042E-05 |
| Normal-vs-Stage3 |
8.4752999999993E-05 |
| Normal-vs-Stage4 |
1.157920E-02 |
| Stage1-vs-Stage2 |
3.154300E-02 |
| Stage1-vs-Stage3 |
5.939500E-02 |
| Stage1-vs-Stage4 |
3.804000E-01 |
| Stage2-vs-Stage3 |
4.952000E-01 |
| Stage2-vs-Stage4 |
5.563400E-01 |
| Stage3-vs-Stage4 |
8.989000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.191000E-04 |
| Normal-vs-AfricanAmerican |
2.741900E-02 |
| Normal-vs-Asian |
2.489500E-02 |
| Caucasian-vs-AfricanAmerican |
9.012200E-01 |
| Caucasian-vs-Asian |
6.375200E-01 |
| AfricanAmerican-vs-Asian |
8.341200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.364200E-02 |
| Normal-vs-Female |
9.82099999999875E-05 |
| Male-vs-Female |
1.581620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.302160E-02 |
| Normal-vs-Age(41-60Yrs) |
3.968800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.792270E-04 |
| Normal-vs-Age(81-100Yrs) |
7.797900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.369250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.999600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.524200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.428200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.417200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.191800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.974270E-04 |
| Classical-VS-Follicular |
6.818900E-03 |
| Classical-VS-Other |
3.871600E-01 |
| Classical-VS-Normal |
1.547580E-02 |
| Tall-VS-Follicular |
2.478600E-01 |
| Tall-VS-Other |
1.591990E-01 |
| Tall-VS-Normal |
1.51650000002057E-06 |
| Follicular-VS-Other |
1.067200E-01 |
| Follicular-VS-Normal |
7.73660000000786E-05 |
| Other-VS-Normal |
9.400400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80126999999031E-05 |
| Normal-vs-N1 |
2.367400E-01 |
| N0-vs-N1 |
1.339040E-01 |
|
|
